InSite Vision's DuraSite 2 Awarded Patent

InSite Vision received a patent for its DuraSite 2 ophthalmic drug delivery system.
The DuraSite 2 was designed to develop topically delivered ocular drugs with enhanced tissue penetration. The patent will protect the technology's delivery system and drugs formulated until 2029.

More Articles on Ophthalmology:
Femtosecond Laser Technology May Provide Alternative to Corneal Keratoplasty
Cataract Surgery Improve Vision in Retinitis Pigmentosa Sufferers, Study Says
Atlantic Eye Center in New Jersey Turns 25

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast